Never before have researchers and vaccine manufacturers faced a challenge of similar dimensions: they are working in a race against time as the world waits for a vaccine that will put an end to the corona pandemic. Serum Institute of India, the world's largest manufacturer of immunobiological drugs and vaccines, is preparing for mass production. Two new mtu emergency power gensets, as well as the existing ones, ensure a reliable power supply.
Serum Institute of India has teamed up with the British pharmaceutical company AstraZeneca to provide a Covid-19 protective vaccine to as many people as possible and as quickly as possible. In partnership with the University of Oxford, AstraZeneca has developed a vaccine that has already been shown to be effective.
The Serum Institute aims to produce one billion doses of vaccine - an ambitious goal that requires not only manpower, but also space and a well-functioning power supply. The company is therefore enlarging its production halls and adding two new mtu gensets from Rolls-Royce to them to be on the safe side. These two new emergency power gensets ensure a continuous supply of electricity. This will enable production to start up at full speed as soon as the vaccine is approved. Each of the two mtu gensets is based on a 20-cylinder mtu Series 20V4000DS3100 Systems and generates a powerful 3000 kVA at 11 kV each.